Gene: L3MBTL4
Official Full Name: L3MBTL histone methyl-lysine binding protein 4provided by HGNC
Gene Summary: Predicted to enable chromatin binding activity and histone binding activity. Predicted to be involved in negative regulation of DNA-templated transcription. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03002 | L3MBTL4 Knockout cell line (HEK293) | Human | L3MBTL4 | 1:3~1:6 | Negative | Online Inquiry |
L3MBTL4 Gene Knockout Cell Lines are expertly engineered cellular models that have had the L3MBTL4 gene specifically disrupted to study its biological functions, regulatory mechanisms, and implications in various diseases. This gene encodes for a protein known to be involved in chromatin remodeling and gene regulation, making its knockout particularly relevant for researchers exploring the pathways of cellular differentiation, proliferation, and cancer biology.
The primary function of these cell lines is to allow researchers to investigate the effects of the loss of L3MBTL4 on cellular behavior and gene expression profiles. This is achieved through the utilization of CRISPR-Cas9 technology, which enables precise editing of the genome. By creating a knockout model, scientists can assess the resultant phenotypic changes, elucidate the pathways impacted by this gene, and identify potential therapeutic targets for conditions where L3MBTL4 is implicated.
The scientific importance of L3MBTL4 Gene Knockout Cell Lines cannot be overstated, as they serve as valuable tools in both academic and clinical research settings. They are particularly useful for understanding the etiology of various cancers and genetic disorders, offering insights that can lead to the development of targeted therapies and personalized medicine strategies.
One unique advantage of our L3MBTL4 Gene Knockout Cell Lines is their reliability and reproducibility. Unlike alternative models that may have variable genetic backgrounds, these engineered lines provide a uniform platform for experimentation, ensuring consistency in results. Furthermore, these cell lines are easily adaptable for high-throughput screening, making them ideal for extensive drug discovery efforts.
Ultimately, the value of L3MBTL4 Gene Knockout Cell Lines lies in their ability to accelerate research in gene function and disease mechanisms, thereby contributing to the advancement of therapeutic approaches. Our company’s extensive expertise in producing high-quality biological products ensures that researchers and clinicians can trust in the performance and reliability of our offerings. By choosing our L3MBTL4 Gene Knockout Cell Lines, you gain a powerful ally in your quest for scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.